Kathleen Tregoning - Insider Trading & Ownership

Entity
Individual
Location
C/O Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston, Massachusetts
Summary
The estimated net worth of Kathleen Tregoning is at least $3.07 M dollars as of May 30, 2024. Kathleen Tregoning is the Title: Chief Corporate Affairs Officer of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. (CERE) stock worth about $2.95 M. Kathleen Tregoning is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $120 K.
All Insider Reports
All Insider Reports

Ownership of Kathleen Tregoning

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERE Cerevel Therapeutics Holdings, Inc. Title: Chief Corporate Affairs Officer $2.95 M -$260 K -8.11% Jan 19, 2024
SPRO Spero Therapeutics, Inc. Director $120 K May 29, 2024

Insider Transactions Reported by Kathleen Tregoning:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership